Skip to main content
Pulsetto logo

Pulsetto

Vilnius, LithuaniaFounded 2021

  • Neuromodulation
  • Seed

Pulsetto develops consumer wellness devices that use vagus nerve stimulation to support relaxation and help users manage stress and anxiety. Its product range includes Pulsetto Lite, Pulsetto FIT, and Pulsetto FIT X, alongside a premium app subscription.

Raised
$3.5M
Feb 2025
Seed
Investors
2
Founded
2021
Employees
11–50

reccy insights

Recent highlights

Pulsetto’s milestones point to expanding consumer reach and a broader emphasis on nervous-system training. On Aug 20, 2025, the company was named Expert Consumers’ top vagus nerve stimulation device for general wellness. A Nov 24, 2025 announcement said Pulsetto had surpassed 100,000 users worldwide, giving a concrete adoption milestone, though it does not disclose retention or revenue. On Jan 8, 2026, Pulsetto announced an integration partnership with Spike API to connect wearable data with its stress-management offering. The company’s 2026 communications also extended its message beyond relaxation: a June 1 announcement discussed nervous-system training for runners, and a July 27 item described NBA players using stress fitness for recovery. These developments suggest the company is broadening its use cases from consumer stress and sleep support toward athletic recovery and wearable-enabled programs. The available announcements do not provide independent study results, commercial terms for the integration, or quantified outcomes from the sports-related initiatives, so their business impact remains unclear.

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

What makes Pulsetto distinct

  1. 01Offers vagus nerve stimulation devices focused on relaxation and stress management.
  2. 02Promotes guided sessions designed to help users relax in under 10 minutes.
  3. 03Offers multiple device models, including Pulsetto Lite, Pulsetto FIT, and Pulsetto FIT X.
  4. 04Pairs its devices with a premium app subscription and guided wellness content.

Technology & products7

  • Pulsetto FIT

    A wearable, non-invasive vagus nerve stimulation device used with a smartphone app to support relaxation, stress management, sleep, and nervous-system regulation.

  • Pulsetto Lite

    A compact, non-invasive vagus nerve stimulation device that delivers guided sessions through the Pulsetto smartphone app for stress relief, relaxation, and sleep support.

  • Pulsetto App Premium

    A subscription-based mobile app upgrade with additional stimulation programs, breathing exercises, meditations, wellness insights, and wearable connectivity.

Recent updates2

  • Jan 8, 2026Partnership

    Pulsetto announced a partnership with Spike API to support wearable integration for stress management.

    einpresswire.com
  • Aug 20, 2025Award

    Top Vagus Nerve Stimulation Device for General Wellness

In the Cortex

Funding

$3.5M disclosed
  • SeedFeb 2025
    $2.1MLed by ScaleWolf
  • SeedFeb 2025
    $419K
  • EU Funding GrantNov 2023
    European Regional Development Fund
2 investors

Similar companies

About Pulsetto

Products
Pulsetto FIT, Pulsetto Lite, Pulsetto App Premium, Pulsetto Gelbox, Travel Case for Pulsetto FIT, Travel Case for Pulsetto Lite, Pulsetto FIT X
Leadership
Povilas Sabaliauskas, Co-Founder & CEOVitalijus Majorovas, Co-Founder
Focus areas
NeuroTechnology, medical devices, digital health, wellness, wearables, vagus nerve stimulation, stress management
Headquarters
Vilnius, Lithuania
Founded
2021
Employees
11–50